Prader-Willi syndrome: an update on obesity and endocrine problems

키워드

참고문헌 (96)

1. Cassidy SB, "Prader-Willi syndrome", Genet Med, 14, pp.10~26 (2012)
2. 전종근, "Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome", Annals of Pediatric Endocrinology & Metabolism, 21(3), pp.126~135 (2016), 대한소아내분비학회
3. Butler MG, "Prader-Willi syndrome-clinical genetics, diagnosis and treatment approaches : an update", Curr Pediatr Rev, 15, pp.207~244 (2019)
4. Irizarry KA, "Prader Willi syndrome : genetics, metabolomics, hormonal function, and new approaches to therapy", Adv Pediatr, 63, pp.47~77 (2016)
5. Rocha CF, "Prader-Willi-like phenotypes : a systematic review of their chromosomal abnormalities", Genet Mol Res, 13, pp.2290~2298 (2014)
6. Angulo MA, "Prader-Willi syndrome : a review of clinical, genetic, and endocrine findings", J Endocrinol Invest, 38, pp.1249~1263 (2015)
7. Driscoll DJ, "GeneReviews®" (2021), University of Washington
8. Bar C, "Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome", Orphanet J Rare Dis, 12, pp.118~ (2017)
9. Harris RM, "Prader Willi syndrome : endocrine updates and new medical therapies", Curr Opin Endocrinol Diabetes Obes, 27, pp.56~62 (2020)
10. Heksch R, "Review of Prader-Willi syndrome : the endocrine approach", Transl Pediatr, 6, pp.274~285 (2017)
11. Miller JL, "Nutritional phases in Prader-Willi syndrome", Am J Med Genet A, 155A, pp.1040~1049 (2011)
12. Gross N, "Prader-Willi syndrome can be diagnosed prenatally", Am J Med Genet A, 167A, pp.80~85 (2015)
13. Lee J, "Disease-specific growth charts for Korean infants with Prader-Willi syndrome", Am J Med Genet A, 167A, pp.86~94 (2015)
14. Rosenbloom ST, "Development and implementation of electronic growth charts for infants with Prader-Willi syndrome", Am J Med Genet A, 158A, pp.2743~2749 (2012)
15. Goldstone AP, "Recommendations for the diagnosis and management of Prader-Willi syndrome", J Clin Endocrinol Metab, 93, pp.4183~4197 (2008)
16. Cassidy SB, "Prader-Willi syndrome", Eur J Hum Genet, 17, pp.3~13 (2009)
17. McCandless SE, "Clinical report-health supervision for children with Prader-Willi syndrome", Pediatrics, 127, pp.195~204 (2011)
18. Whittington JE, "Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region", J Med Genet, 38, pp.792~798 (2001)
19. Butler MG, "Causes of death in Prader-Willi syndrome : Prader-Willi Syndrome Association(USA)40-year mortality survey", Genet Med, 19, pp.635~642 (2017)
20. Pacoricona Alfaro DL, "Causes of death in Prader-Willi syndrome : lessons from 11 years' experience of a national reference center", Orphanet J Rare Dis, 14, pp.238~ (2019)
21. Lionti T, "Prader-Willi syndrome in Victoria : mortality and causes of death", J Paediatr Child Health, 48, pp.506~511 (2012)
22. Butler MG, "Energy expenditure and physical activity in Prader-Willi syndrome : comparison with obese subjects", Am J Med Genet A, 143A, pp.449~459 (2007)
23. Burman P, "Endocrine dysfunction in Prader-Willi syndrome : a review with special reference to GH", Endocr Rev, 22, pp.787~799 (2001)
24. Khan MJ, "Mechanisms of obesity in Prader-Willi syndrome", Pediatr Obes, 13, pp.3~13 (2018)
25. Holsen LM, "Importance of reward and prefrontal circuitry in hunger and satiety : Prader-Willi syndrome vs simple obesity", Int J Obes(Lond), 36, pp.638~647 (2012)
26. Blanco-Hinojo L, "Lack of response to disgusting food in the hypothalamus and related structures in Prader Willi syndrome", Neuroimage Clin, 21, pp.101662~ (2019)
27. Dimitropoulos A, "Food-related neural circuitry in Prader-Willi syndrome : response to high-versus lowcalorie foods", J Autism Dev Disord, 38, pp.1642~1653 (2008)
28. DelParigi A, "High circulating ghrelin : a potential cause for hyperphagia and obesity in prader-willi syndrome", J Clin Endocrinol Metab, 87, pp.5461~5464 (2002)
29. Haqq AM, "Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome", J Clin Endocrinol Metab, 88, pp.174~178 (2003)
30. Kweh FA, "Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia", Am J Med Genet A, 167A, pp.69~79 (2015)
31. Beauloye V, "High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome", Orphanet J Rare Dis, 11, pp.56~ (2016)
32. Lawson EA, "The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis", J Neuroendocrinol, 32, pp.e12805~ (2020)
33. Swaab DF, "Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons(putative satiety cells)in Prader-Willi syndrome : a study of five cases", J Clin Endocrinol Metab, 80, pp.573~579 (1995)
34. Martin A, "Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome : a preliminary report", Biol Psychiatry, 44, pp.1349~1352 (1998)
35. Johnson L, "Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings", Am J Med Genet A, 170, pp.594~601 (2016)
36. Xue Q, "Ghrelin through GHSR1a and OX1R heterodimers reveals a Galphas-cAMP-cAMP response element binding protein signaling pathway in vitro", Front Mol Neurosci, 11, pp.245~ (2018)
37. Wallace Fitzsimons SE, "A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling", Neuropharmacology, 152, pp.90~101 (2019)
38. Kuppens RJ, "Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome : a randomized, double-blind, controlled crossover trial", Clin Endocrinol(Oxf), 85, pp.979~987 (2016)
39. Miller JL, "Oxytocin treatment in children with Prader-Willi syndrome : a double-blind, placebo-controlled, crossover study", Am J Med Genet A, 173, pp.1243~1250 (2017)
40. Allas S, "AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome : a randomized placebo-controlled trial", PLoS One, 13, pp.e0190849~ (2018)
41. Butler MG, "Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome", J Pediatr Endocrinol Metab, 17, pp.1177~1184 (2004)
42. Hoybye C, "Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment", Eur J Endocrinol, 151, pp.457~461 (2004)
43. Butler MG, "Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome", Am J Med Genet A, 143A, pp.415~421 (2007)
44. Haqq AM, "Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome(PWS) : association with insulin sensitivity and circulating satiety peptide hormones", Clin Endocrinol(Oxf), 67, pp.944~951 (2007)
45. Park WH, "Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome", J Clin Endocrinol Metab, 92, pp.229~234 (2007)
46. Haqq AM, "The metabolic phenotype of Prader-Willi syndrome(PWS)in childhood : heightened insulin sensitivity relative to body mass index", J Clin Endocrinol Metab, 96, pp.E225~E232 (2011)
47. Goldstone AP, "Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome", Int J Obes(Lond), 36, pp.1564~1570 (2012)
48. Orsso CE, "Obestatin and adropin in Prader-Willi syndrome and nonsyndromic obesity : associations with weight, BMI-z, and HOMA-IR", Pediatr Obes, 14, pp.e12493~ (2019)
49. Butler MG, "Comparison of leptin protein levels in Prader-Willi syndrome and control individuals", Am J Med Genet, 75, pp.7~12 (1998)
50. Bochukova EG, "Transcriptomics of the Prader-Willi syndrome hypothalamus", Handb Clin Neurol, 181, pp.369~379 (2021)
51. Bochukova EG, "A transcriptomic signature of the hypothalamic response to fasting and BDNF deficiency in Prader-Willi syndrome", Cell Rep, 22, pp.3401~3408 (2018)
52. Gray J, "Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor(BDNF)gene", Diabetes, 55, pp.3366~3371 (2006)
53. Han JC, "Lower brain-derived neurotrophic factor in patients with prader-willi syndrome compared to obese and lean control subjects", J Clin Endocrinol Metab, 95, pp.3532~3536 (2010)
54. Lloret-Linares C, "Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity", Int J Obes(Lond), 37, pp.1198~1203 (2013)
55. Lacroix D, "Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome : a model of extreme adiposity", J Clin Endocrinol Metab, 100, pp.850~859 (2015)
56. Yazdi PG, "Differential gene expression reveals mitochondrial dysfunction in an imprinting center deletion mouse model of Prader-Willi syndrome", Clin Transl Sci, 6, pp.347~355 (2013)
57. Butler MG, "Preliminary observations of mitochondrial dysfunction in Prader-Willi syndrome", Am J Med Genet A, 176, pp.2587~2594 (2018)
58. Schmidt H, "Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome : a ten-year follow-up", J Pediatr Endocrinol Metab, 21, pp.651~655 (2008)
59. Miller JL, "Approach to the child with prader-willi syndrome", J Clin Endocrinol Metab, 97, pp.3837~3844 (2012)
60. Crino A, "Obesity management in Prader-Willi syndrome : current perspectives", Diabetes Metab Syndr Obes, 11, pp.579~593 (2018)
61. Griggs JL, "Prader-Willi syndrome : From genetics to behaviour, with special focus on appetite treatments", Neurosci Biobehav Rev, 59, pp.155~172 (2015)
62. Sipila I, "Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome", Acta Paediatr, 99, pp.1712~1718 (2010)
63. Scheimann AO, "Critical analysis of bariatric procedures in Prader-Willi syndrome", J Pediatr Gastroenterol Nutr, 46, pp.80~83 (2008)
64. Salehi P, "Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome", Pediatr Obes, 12, pp.221~228 (2017)
65. Yoo-Mi Kim, "Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome", Annals of Pediatric Endocrinology & Metabolism, 25(1), pp.52~56 (2020), 대한소아내분비학회
66. Senda M, "The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome", Endocr J, 59, pp.889~894 (2012)
67. Fintini D, "Use of GLP-1 receptor agonists in Prader-Willi Syndrome : report of six cases", Diabetes Care, 37, pp.e76~e77 (2014)
68. Kimonis V, "A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome", PLoS One, 14, pp.e0221615~ (2019)
69. Einfeld SL, "A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome", Am J Med Genet A, 164A, pp.2232~2239 (2014)
70. Hollander E, "Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome : a randomized controlled pilot trial", J Psychiatr Res, 137, pp.643~651 (2021)
71. Tauber M, "The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome", Pediatrics, 139, pp.e20162976~ (2017)
72. Dykens EM, "Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome", JCI Insight, 3, pp.e98333~ (2018)
73. Bridges N, "What is the value of growth hormone therapy in Prader Willi syndrome", Arch Dis Child, 99, pp.166~170 (2014)
74. Cohen M, "Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome", Clin Endocrinol(Oxf), 83, pp.212~215 (2015)
75. Carrel AL, "Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome", J Clin Endocrinol Metab, 95, pp.1131~1136 (2010)
76. Myers SE, "Two years of growth hormone therapy in young children with Prader-Willi syndrome : physical and neurodevelopmental benefits", Am J Med Genet A, 143A, pp.443~448 (2007)
77. Donze SH, "Improved mental and motor development during 3 years of GH treatment in very young children with Prader-Willi syndrome", J Clin Endocrinol Metab, 103, pp.3714~3719 (2018)
78. Grugni G, "Diagnosis and treatment of GH deficiency in Prader-Willi syndrome", Best Pract Res Clin Endocrinol Metab, 30, pp.785~794 (2016)
79. Koizumi M, "Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome", Endocr J, 65, pp.1127~1137 (2018)
80. Hoybye C, "Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome", J Intellect Disabil Res, 49(Pt 4), pp.245~252 (2005)
81. Damen L, "Three years of growth hormone treatment in young adults with Prader-Willi syndrome : sustained positive effects on body composition", Orphanet J Rare Dis, 15, pp.163~ (2020)
82. Grugni G, "Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome", Clin Endocrinol(Oxf), 65, pp.492~499 (2006)
83. Butler MG, "Thyroid function studies in Prader-Willi syndrome", Am J Med Genet A, 143A, pp.488~492 (2007)
84. Diene G, "Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database", Horm Res Paediatr, 74, pp.121~128 (2010)
85. Iughetti L, "Thyroid function in patients with Prader-Willi syndrome : an Italian multicenter study of 339patients", J Pediatr Endocrinol Metab, 32, pp.159~165 (2019)
86. Vaiani E, "Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life", Clin Endocrinol(Oxf), 73, pp.546~550 (2010)
87. de Lind van Wijngaarden RF, "High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome", J Clin Endocrinol Metab, 93, pp.1649~1654 (2008)
88. Grugni G, "Central adrenal insufficiency in young adults with Prader-Willi syndrome", Clin Endocrinol(Oxf), 79, pp.371~378 (2013)
89. Farholt S, "Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome", J Clin Endocrinol Metab, 96, pp.E173~E180 (2011)
90. Corrias A, "Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome", Clin Endocrinol(Oxf), 76, pp.843~850 (2012)
91. Oto Y, "Delayed peak response of cortisol to insulin tolerance test in patients with Prader-Willi syndrome", Am J Med Genet A, 176, pp.1369~1374 (2018)
92. Muscogiuri G, "Prader-Willi syndrome : an uptodate on endocrine and metabolic complications", Rev Endocr Metab Disord, 20, pp.239~250 (2019)
93. Tauber M, "Endocrine disorders in Prader-Willi syndrome : a model to understand and treat hypothalamic dysfunction", Lancet Diabetes Endocrinol, 9, pp.235~246 (2021)
94. Crino A, "Hypogonadism and pubertal development in Prader-Willi syndrome", Eur J Pediatr, 162, pp.327~333 (2003)
95. Eldar-Geva T, "Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi Syndrome", Horm Res, 72, pp.153~159 (2009)
96. Greco D, "Prader-Willi syndrome with angelman syndrome in the offspring", Medicina(Kaunas), 57, pp.460~ (2021)

관련 논문AI추천